Orthofix Medical Inc. (OFIX) revealed Loss for third quarter of -$22.80 million
The company's bottom line totaled -$22.80 million, or -$0.57 per share. This compares with -$27.39 million, or -$0.71 per share, last year.
The company's revenue for the period rose 4.6% to $205.63 million from $196.61 million last year.
Orthofix Medical Inc. earnings at a glance (GAAP) :
-Earnings: -$22.80 Mln. vs. -$27.39 Mln. last year.-EPS: -$0.57 vs. -$0.71 last year.-Revenue: $205.63 Mln vs. $196.61 Mln last year.
he Company is narrowing its FY25 net sales guidance range to $810 million to $814 million from the previous guidance of $808 million to $816 million
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.